Recordati Industria Chimica e Farmaceutica SpA (RECm)

CBOE (Milan)Healthcare

€46.3
-€1.25 (-2.6%)
Last close

January 21, 2026 at 16:30 UTC

Interactive Chart
RECm
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Recordati Industria Chimica e Farmaceutica SpA

Name

Recordati Industria Chimica e Farmaceutica SpA

CEO

Robert Koremans

Industry

Healthcare

Year Founded

1926

Employees

4,580

Recordati Industria Chimica e Farmaceutica SpA is a healthcare company that researches, manufactures, and supplies medicines used in specialized and primary care. Development programs are designed to produce labeling that clinicians can apply without changing routine practice, and medical information is updated through controlled channels. Manufacturing follows validated procedures, and logistics are planned to protect continuity at pharmacies, hospitals, and distributors. Regional teams handle access within local frameworks while core quality and pharmacovigilance remain centralized. Public communication favors operational facts rather than narrative claims.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 2 Buy, 6 Hold, 16 Sell
Buy2
Hold6
Sell16
Fundamentals & Financials
Revenue (TTM)
€2.5B
Net Income (TTM)
€404.3M
EPS (TTM)
€1.97
ROA (TTM)
7.63%
Current Ratio
1.64
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue€632,321K
Cost of Sales€199,913K
Gross Profit€432,408K
Operating Income€165,642K
Net Income€110,165K
EPS€0.54
Technical Indicators

Recordati Industria Chimica e Farmaceutica SpA's Technical Indicators Summary

RECm is displaying a predominantly bearish profile as it trades below key moving averages, including the 10-day and 200-day EMAs, indicating sustained downward pressure. Momentum indicators such as the MACD and CCI reinforce this negative sentiment, with both signaling selling conditions, while the RSI remains near the lower range, suggesting limited buying interest. The ADX value points to a weak trend, implying that the current bearish momentum may lack strong conviction. Meanwhile, volatility remains steady, supported by a moderate ATR reading, and although the OBV shows some accumulation, the price remains beneath the VWAP and classic pivot levels, which are acting as resistance. Overall, the technical landscape favors bears with no clear reversal in sight.

Buy
2 signals
Neutral
6 signals
Sell
16 signals
Overall: Bearish67% Bearish signals
IndicatorValue
RSI (14)
38.98
Stochastic %K (14, 3, 3)
19.97
CCI (20)
-219.62
WPR (14)
-79.37
Momentum (10)
-0.60
MFI
39.74
MACD Level (12, 26)
-0.38
Bollinger Bands
$47.09 - $49.65
ATR (14)
$0.88 (1.85%)
ADX (14)
15.00
OBV
-4,223,369
VWAP
$47.35
Classic Pivot Point
$47.71
Fibonacci Pivot Point
$47.71
Exponential Moving Averages
$48.13 - $51.51(5 indicators)
Simple Moving Averages
$48.37 - $51.44(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the final tick, sector performance was mildly positive (1.16%), giving a light assist to the overall tone. By the close, volatility had eased back, with VIX down -11.71% on the session. REC.MI's mildly positive sector performance and easing volatility support a steady price tone.

Price Change

from €47.48 close

€-0.72

Trading Volume

Below avg (342.3K)

155.3K

vs S&P 500 Today

Underperforming Market

-1.58%

52-Week Position

Lower range

16.4%

Updated: January 21, 2026 at 15:40 UTC

Quote Summary
OpenPrevious Close
€47.22€47.48
Day Range52 Week Range
€46.28 - €47.6€43.98 - €60.95
VolumeAvg. Volume
330.5K293.6K
Market CapP/E Ratio
€9.4B24.1
Peers & Related Assets